80047931 - OncologyConsults: Emerging Options for Treating Small Cell Lung Cancer: The Potential Role of Checkpoint Inhibitors



Date & Location
Tuesday, March 26, 2019, 12:00 AM - Tuesday, March 31, 2020, 12:00 AM

Target Audience
Specialties - Nurse Practitioner, Nursing, Oncology, Physician Assistant

Overview
OncologyConsults.com is a learning portal that will address knowledge, competence and clinical practice gaps among clinicians who care for patients with cancers. The metastatic module will be developed for November, 2018 availability, with accreditation availability for one year from posting date. As needed, content will be updated to reflect new guidelines, evidence, and/or best practices, as deemed necessary by the course director and module author.

https://www.oncologyconsults.com/Home/CEData?id=789

Objectives
After participating in this activity, the participant will demonstrate the ability to:

  1. Recognize the need for interventions that can improve SCLC prognosis and the rationale for using ICIs for this purpose.
  2. Evaluate recent literature regarding the efficacy & safety of ICIs in SCLC patients.
  3. Assess the potential clinical implications of ICI therapy for SCLC patients.
  4. Implement strategies to assess, recognize and manage irAEs in patients treated with ICIs.

Keywords: ONLINE